The use of an exclusion-based risk-assessment model for venous thrombosis improves uptake of appropriate thromboprophylaxis in hospitalized medical patients

作者: C. Bagot , S. Gohil , R. Perrott , S. Barsam , R. K. Patel

DOI: 10.1093/QJMED/HCQ100

关键词:

摘要: Background: Venous thromboembolism is a common condition in hospitalized medical patients. Numerous studies have demonstrated that low molecular weight heparin significantly reduces this risk but, despite this, the use of thromboprophylaxis remains poor. Aim: To evaluate an exclusion based risk-assessment model (RAM) for venous thrombosis improving uptake appropriate patients. Design: A survey with subsequent audit cycle three separate audits over 36 months. Methods: 497 patients acute conditions on general wards were audited at secondary care centre London, UK. The and performed by reviewing notes medication charts patients, prior to launch RAM 12, 28 months following its introduction. Results: Prior launching RAM, 49% received thromboprophylaxis. This did not change 12 after was introduced but increased 71% formal education health professionals involved prescription. improvement maintained as 8 later (75.9%). Conclusions: introduction simple exclusion-based improved delivery successful appears been dependent direct those carers use. similar used nationally could significant impact burden VTE currently experienced

参考文章(50)
Claude Gallinari, Anne-Sophie Grancher, Jean-Pierre Vincent, Henri Naga, Joel Belmin, Rosella Salvatore, Marie Kazes, Eric Pautas, André Boiffin, Jean-Bernard Piera, Monique Duviquet, David Knafo, Andrée Piau, Dragoslav Miric, Alain Jean, Valérie Bellamy, Olivier Tissandier, Alain-Ferdinand Le Blanche, Sébastien Weill-Engerer, Sylvie Meaume, Amina Lahlou, François Piette, Olivier Saint-Jean, Annick Sachet, Jean-Yves Beinis, Risk Factors for Deep Vein Thrombosis in Inpatients Aged 65 and Older: A Case‐Control Multicenter Study Journal of the American Geriatrics Society. ,vol. 52, pp. 1299- 1304 ,(2004) , 10.1111/J.1532-5415.2004.52359.X
Wisgarten J, Freund E, Manor A, Pajewski M, Modai D, Starinski R, Iatrogenic arterial aneurysm associated with ergotamine therapy. The Lancet. ,vol. 2, pp. 934- ,(1981)
P. CHOPARD, J. DÖRFFLER-MELLY, U. HESS, W. A. WUILLEMIN, D. HAYOZ, A. GALLINO, E. B. BACHLI, C. R. CANOVA, J. ISENEGGER, R. RUBINO, H. BOUNAMEAUX, Venous thromboembolism prophylaxis in acutely ill medical patients: definite need for improvement. Journal of Internal Medicine. ,vol. 257, pp. 352- 357 ,(2005) , 10.1111/J.1365-2796.2005.01455.X
Alain Leizorovicz, Alexander Cohen, Alexander Turpie, Carl-Gustav Olsson, Samuel Goldhaber, Paul Vaitkus, , Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients Thrombosis and Haemostasis. ,vol. 93, pp. 76- 79 ,(2004) , 10.1160/TH04-05-0323
T P Baglin, K White, A Charles, Fatal pulmonary embolism in hospitalised medical patients. Journal of Clinical Pathology. ,vol. 50, pp. 609- 610 ,(1997) , 10.1136/JCP.50.7.609
P A Sandercock, A G van den Belt, R I Lindley, J Slattery, Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. Journal of Neurology, Neurosurgery, and Psychiatry. ,vol. 56, pp. 17- 25 ,(1993) , 10.1136/JNNP.56.1.17
Alexander T. Cohen, Raza Alikhan, Prophylaxis of venous thromboembolism in medical patients. Current Opinion in Pulmonary Medicine. ,vol. 7, pp. 332- 337 ,(2001) , 10.1097/00063198-200109000-00014